For patients who reached the Medicare Part D coverage gap, discontinuation was more likely for patients taking osteoporosis medication.
Daniel E. Ball, DrPH
Advertisement
Articles by Daniel E. Ball, DrPH
Advertisement
Latest Updated Articles
- Persistence With Biologic Therapies in the Medicare Coverage Gap
Published: November 7th 2011 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Prescription Access Crisis: 40% of GLP-1 RA Rx Are Unfilled
2
Responsible Use of Energy-Based Treatments on Skin of Color: Eliot F. Battle, MD
3
New WHO Reports Sounds Alarm on Antimicrobial Resistance
4
Guideline-Directed Medical Therapies in Heart Failure
5
